Characteristic | Baseline |
---|---|
Age (years), mean ± SD | 69.4 ± 3.8 |
Males, n/total | 10/10 |
BMI (kg/m2), mean ± SD | 26.3 ± 2.4 |
Cardiovascular risk factors, n/total | |
Current smoking | 7/10 |
Diabetes mellitus | 6/10 |
Hypertension | 10/10 |
Hypercholesterolemia | 9/10 |
Family history of CAD | 6/10 |
Medical history, n/total | |
Prior CABG | 10/10 |
Prior MI | 7/10 |
Prior PCI | 8/10 |
Prior ICD implant | 2/10 |
Spinal cord stimulation | 2/10 |
Peripheral vascular disease | 1/10 |
Current medications, n/total | |
β-Blockers | 9/10 |
ACE inhibitors | 5/10 |
ARBs | 3/10 |
Calcium antagonists | 1/10 |
Diuretics | 6/10 |
Statins | 10/10 |
Aspirin | 8/10 |
Ranolazine | 7/10 |
Long-lasting nitroglycerin | 6/10 |
Cardiovascular condition at enrolment, mean ± SD | |
LVEF (%) | 38.3 ± 5.1 |
LV reversible ischemia (%) | 15.3 ± 8.4 |
Peak VO2 (ml/kg/min) | 13.3 ± 1.8 |